Alzheimer's disease is no longer a condition clinicians simply observe and refer. With 50 million people currently living with dementia worldwide and that number projected to triple by 2050, the clinical landscape demands a more proactive, evidence-informed approach. The intersection of functional neurology, lifestyle medicine, and cognitive neuroscience has opened a window of intervention that most clinical training programs have yet to fully address. This course, led by Dr. Ted Carrick, positions clinicians inside that window.

The Diagnosis and Treatment of Alzheimer's Disease with Emphasis on Lifestyle Modification translates current consensus science into immediate clinical capability. Drawing from the Lancet Commission reports, published meta-analyses, and Dr. Carrick's own peer-reviewed research in neurodegeneration, vestibular rehabilitation, and brain injury, this course builds a working framework around the 12 evidence-based modifiable risk factors now known to account for 40% of Alzheimer's disease prevalence. Clinicians gain the ability to assess cognitive reserve, interpret early structural biomarkers, apply valid memory screening tools, and design patient-specific lifestyle interventions grounded in current neuroscience. The course also addresses the neurobiology of hearing loss, physical inactivity, metabolic dysfunction, social isolation, and environmental exposures as they relate to progressive cognitive decline.

This course is designed for licensed healthcare clinicians who encounter aging populations and neurologically complex patients and who recognize that the space between normal cognition and dementia diagnosis is where clinical impact is greatest. Chiropractors, chiropractic neurologists, physical therapists, and other allied health professionals seeking evidence-based approaches to Alzheimer's prevention and management will find this content immediately applicable.